All eye drop users should check out the FDA's list of 26 different eye drops that could cause infection or even blindness. The FDA has reported that Velocity Pharma manufactured its eye drops under ...

Shares of Lupin are set to be in focus after it received US FDA approval for its generic Loteprednol Etabonate Ophthalmic Gel ...

LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market ...

A novel eye drop formulation shows antioxidant effects and may protect corneal epithelial cells, according to research presented at AOA 2025.

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

Lifitegrast 5.0%, a topical anti-inflammatory therapy, effectively reduces signs and biomarkers of dry eye disease in 12 ...

An optometrist shares why this seemingly harmless item can lead to bigger issues with your eye health. View Entire Post › ...

Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!

Multi-modality fusion strategy is currently the de-facto most competitive solution for 3D perception tasks. In this work, we present a new framework termed BEVFormer, which learns unified BEV ...

Results Of 40 included patients, 39 completed the trial. Both tested rhNGF eye drop concentrations were safe and well tolerated. Twenty-nine patients experienced at least one AE (14 in G1 and 15 in G2 ...

Now, is Palantir set to drop nearly 30% as the average Wall Street forecast suggests? No, Palantir stock isn't necessarily heading for tough times in the months to come.

Because the story struggles to split the difference between cheap thrills and atmospheric unease, it becomes difficult to stay invested in Eye for an Eye. Even at just over 100 minutes in length (just ...